Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn’s Disease: A Post Hoc Analysis of 3 Phase 3 Trials
Clinical Gastroenterology and Hepatology · 2025-05 · 23 (6) · 1019-1029
DOI: 10.1016/j.cgh.2024.08.032 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025-05. Verfasst von Jean-Frédéric Colombel und 13 weiteren Autor:innen. Beteiligte Einrichtung: Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic addre…. Hauptthemen laut MEDLINE: Crohn Disease, Heterocyclic Compounds, 3-Ring, Rectal Fistula, Janus Kinase Inhibitors. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AbbVie Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: jean-frederic.colombel@mssm.edu.
- AbbVie Inc., North Chicago, Illinois.
- IBD Centre, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
- Inflammatory Bowel Disease Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada.
- Department of Internal Medicine, Medical University of Vienna, Vienna, Austria.
- Department of Gastroenterology, Hepatology, and Nutrition, Digestive Diseases Institute, Cleveland Clinic, Cleveland, Ohio.
Förderung
- AbbVie Inc
Zitieren
APA
Colombel, J. F., Lacerda, A. P., Irving, P. M., Panaccione, R., Reinisch, W., Rieder, F., Steinlauf, A., Schwartz, D., Feng, T., Dubcenco, E., Anyanwu, S. I., Laroux, F. S., Cunneen, C., & Powell, N. (2025). Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn’s Disease: A Post Hoc Analysis of 3 Phase 3 Trials. Clinical Gastroenterology and Hepatology, 23(6), 1019-1029. https://doi.org/10.1016/j.cgh.2024.08.032
Vancouver
Colombel JF, Lacerda AP, Irving PM, Panaccione R, Reinisch W, Rieder F, et al. Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn’s Disease: A Post Hoc Analysis of 3 Phase 3 Trials. Clinical Gastroenterology and Hepatology. 2025;23(6):1019-1029. doi:10.1016/j.cgh.2024.08.032
BibTeX
@article{Colombel2025,
author = {Colombel, Jean-Frédéric and Lacerda, Ana P and Irving, Peter M and Panaccione, Remo and Reinisch, Walter and Rieder, Florian and Steinlauf, Adam and Schwartz, David and Feng, Tian and Dubcenco, Elena and Anyanwu, Samuel I and Laroux, F Stephen and Cunneen, Colla and Powell, Nick},
title = {Efficacy and Safety of Upadacitinib for Perianal Fistulizing Crohn’s Disease: A Post Hoc Analysis of 3 Phase 3 Trials},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
volume = {23},
number = {6},
pages = {1019--1029},
doi = {10.1016/j.cgh.2024.08.032}
}
EUVIMED